15.18
price down icon3.19%   -0.50
pre-market  Pre-mercato:  15.13   -0.05   -0.33%
loading

Adma Biologics Inc Borsa (ADMA) Ultime notizie

pulisher
Feb 26, 2026

ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance - Finviz

Feb 26, 2026
pulisher
Feb 26, 2026

Westfield Capital Management Co. LP Takes $74.87 Million Position in ADMA Biologics Inc $ADMA - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

New ADMA Biologics CFO Takes Helm As Valuation Gap Draws Focus - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

ADMA Biologics Inc (ADMA) Q4 2025 Earnings Call Highlights: Stro - GuruFocus

Feb 26, 2026
pulisher
Feb 25, 2026

ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics (ADMA) Reports Strong 2025 Results and Positive O - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway - MSN

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Q4 Earnings Call Highlights - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Says Brad Tade Is Retiring As Chief Financial Officer - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: ADMA Biologics reports strong Q4 2025 growth - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics (NASDAQ:ADMA) Issues Quarterly Earnings Results - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA BIOLOGICS, INC. SEC 10-K Report - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

(ADMA) ADMA Biologics Expects 2026 Revenue to Exceed $635M, vs. FactSet Est of $633.8M - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

Adma Biologics: Fourth Quarter Financial Overview - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Announces CFO Transition and Leadership Change - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Adma Biologics: Q4 Earnings Snapshot - Barchart.com

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics CFO Brad Tade retires; Terry Kohler promoted to CFO - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics, Inc. Announces Chief Financial Officer Changes - marketscreener.com

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics earnings up next: Can momentum match lofty targets? By Investing.com - Investing.com Canada

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics earnings up next: Can momentum match lofty targets? - Investing.com India

Feb 25, 2026
pulisher
Feb 25, 2026

Aug Outlook: Is ADMA Biologics Inc attractive for institutional investorsGap Down & Weekly High Return Stock Opportunities - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 24, 2026

Aug Outlook: Whats the beta of ADMA Biologics Inc stockMarket Activity Recap & Short-Term Swing Trade Alerts - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

ADMA Biologics to Announce Q4 Earnings on February 25 - Intellectia AI

Feb 24, 2026
pulisher
Feb 24, 2026

Preview: ADMA Biologics's Earnings - Benzinga

Feb 24, 2026
pulisher
Feb 24, 2026

What To Expect From ADMA Biologics Inc (ADMA) Q4 2025 Earnings - GuruFocus

Feb 24, 2026
pulisher
Feb 23, 2026

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech With A 59.42% Potential Upside - DirectorsTalk Interviews

Feb 23, 2026
pulisher
Feb 23, 2026

ADMA Biologics (ADMA) to Release Quarterly Earnings on Monday - MarketBeat

Feb 23, 2026
pulisher
Feb 19, 2026

Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Feb 19, 2026
pulisher
Feb 19, 2026

Aberdeen Group plc Increases Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

ADMA Biologics CEO Sale And Options Activity Versus Valuation And Momentum - Yahoo Finance

Feb 18, 2026
pulisher
Feb 18, 2026

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative

Feb 18, 2026
pulisher
Feb 17, 2026

Adam Grossman, president of Adma Biologics, sells $337,679 in shares By Investing.com - Investing.com South Africa

Feb 17, 2026
pulisher
Feb 17, 2026

Adam Grossman, president of Adma Biologics, sells $337,679 in shares - Investing.com

Feb 17, 2026
pulisher
Feb 17, 2026

(ADMA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Feb 17, 2026
pulisher
Feb 17, 2026

ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking a 59.52% Upside in the Biotech Arena - DirectorsTalk Interviews

Feb 17, 2026
pulisher
Feb 16, 2026

Public Sector Pension Investment Board Acquires 116,867 Shares of ADMA Biologics Inc $ADMA - MarketBeat

Feb 16, 2026
pulisher
Feb 16, 2026

Assessing ADMA Biologics (ADMA) Valuation After Recent Share Price Rebound - Sahm

Feb 16, 2026
pulisher
Feb 15, 2026

Market Leaders: Can ADMA Biologics Inc outperform in the next rallyJuly 2025 Analyst Calls & Risk Controlled Stock Alerts - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 13, 2026

What are ADMA Biologics Inc.’s growth leversJuly 2025 Review & Community Trade Idea Sharing Platform - mfd.ru

Feb 13, 2026
pulisher
Feb 13, 2026

Aug Movers: What is the cash position of REPXJuly 2025 Weekly Recap & Target Return Focused Picks - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Nasdaq

Feb 12, 2026
pulisher
Feb 12, 2026

Navellier & Associates Inc. Has $176,000 Stake in ADMA Biologics Inc $ADMA - MarketBeat

Feb 12, 2026
pulisher
Feb 09, 2026

New York State Common Retirement Fund Decreases Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Principal Financial Group Inc. Cuts Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

ADMA Biologics Inc (ADMA) Stock Analysis: Attractive 56.22% Upside Potential For Investors - DirectorsTalk Interviews

Feb 09, 2026
pulisher
Feb 07, 2026

Renaissance Group LLC Has $7.57 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

(ADMA) Risk Channels and Responsive Allocation - Stock Traders Daily

Feb 06, 2026
pulisher
Feb 05, 2026

Assessing ADMA Biologics (ADMA) Valuation After Growing Analyst Optimism On Earnings And Plasma Therapy Pipeline - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

Homestead Advisers Corp Has $2.91 Million Position in ADMA Biologics Inc $ADMA - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Is ADMA Biologics (ADMA) Pricing Reflect A Potential Gap To DCF And P/E Estimates - Yahoo Finance

Feb 05, 2026
pulisher
Feb 03, 2026

ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Rather Sparingly - 富途牛牛

Feb 03, 2026
pulisher
Feb 02, 2026

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Feb 02, 2026
pulisher
Feb 02, 2026

Federated Hermes Inc. Reduces Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking A 48% Potential Upside - DirectorsTalk Interviews

Feb 02, 2026
pulisher
Feb 02, 2026

Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

ADMA Biologics Inc $ADMA Shares Bought by Thrivent Financial for Lutherans - MarketBeat

Feb 02, 2026
pulisher
Feb 01, 2026

Is it worth investing in Adma Biologics (ADMA) based on Wall Street's bullish views? - MSN

Feb 01, 2026
pulisher
Jan 31, 2026

Aug Movers: Does Assured Guaranty Ltd have strong EBITDA marginsJuly 2025 Gainers & Reliable Price Action Trade Plans - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 31, 2026

Returns Recap: Is Celularity Inc Equity Warrant forming higher highs and higher lowsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 31, 2026

ADMA Biologics Inc $ADMA Shares Sold by Lisanti Capital Growth LLC - MarketBeat

Jan 31, 2026
pulisher
Jan 29, 2026

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - Finviz

Jan 29, 2026
$100.09
price up icon 0.11%
$51.71
price up icon 0.66%
$28.49
price down icon 0.59%
$108.80
price down icon 0.95%
$150.00
price up icon 0.94%
biotechnology ONC
$322.37
price down icon 8.48%
Capitalizzazione:     |  Volume (24 ore):